Radiation therapy for prostate cancer: What's the best in 2021

Francesco Cellini, Luca Tagliaferri, Vincenzo Frascino, Anna Rita Alitto, Bruno Fionda, Luca Boldrini, Angela Romano, Calogero Cas(`(a)), Francesco Catucci, Gian Carlo Mattiucci, Vincenzo Valentini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

Radiotherapy is highly involved in the management of prostate cancer. Its features and potential applications experienced a radical evolution over last decades, as they are associated to the continuous evolution of available technology and current oncological innovations. Some application of radiotherapy like brachytherapy have been recently enriched by innovative features and multidisciplinary dedications. In this report we aim to put some questions regarding the following issues regarding multiple aspects of modern application of radiation oncology: the current application of radiation oncology; the modern role of stereotactic body radiotherapy (SBRT) for both the management of primary lesions and for lymph-nodal recurrence; the management of the oligometastatic presentations; the role of brachytherapy; the aid played by the application of the organ at risk spacer (spacer OAR), fiducial markers, electromagnetic tracking systems and on-line Magnetic Resonance guided radiotherapy (MRgRT), and the role of the new opportunity represented by radiomic analysis.
Lingua originaleEnglish
pagine (da-a)5-15
Numero di pagine11
RivistaUrologia
Volume89
DOI
Stato di pubblicazionePubblicato - 2021

Keywords

  • Humans
  • MR guided RT
  • Male
  • Prostate cancer
  • Prostatic Neoplasms
  • Radiosurgery
  • Radiotherapy, Image-Guided
  • SBRT
  • brachytherapy
  • fiducials
  • hypofractionation
  • interventional radiation therapy
  • radiotherapy

Fingerprint

Entra nei temi di ricerca di 'Radiation therapy for prostate cancer: What's the best in 2021'. Insieme formano una fingerprint unica.

Cita questo